{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:58:06Z","timestamp":1792627086923,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222059"],"award-info":[{"award-number":["82222059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330096"],"award-info":[{"award-number":["82330096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coi.2025.102580","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:53:03Z","timestamp":1748623983000},"page":"102580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Epigenetic regulation in vitiligo: mechanisms, challenges, and therapeutic opportunities"],"prefix":"10.1016","volume":"95","author":[{"given":"Linxuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingrui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102580_sbref1","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.coi.2025.102580_bib2","article-title":"Clinical features of vitiligo and social impact on quality of life","volume":"13","author":"Seneschal","year":"2023","journal-title":"Dermatol Pr Concept"},{"key":"10.1016\/j.coi.2025.102580_bib3","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1007\/s12325-024-02875-0","article-title":"Epidemiology and treatment patterns of patients with vitiligo: a real-world Analysis","volume":"41","author":"Ramot","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.coi.2025.102580_bib4","article-title":"A comprehensive review on present and future of pharmacotherapy of vitiligo disease and potential therapeutic strategies","volume":"3","author":"Moghadam","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.coi.2025.102580_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.15743","article-title":"Vitiligo: a focus on pathogenesis and its therapeutic implications","volume":"48","author":"Bergqvist","year":"2021","journal-title":"J Dermatol"},{"issue":"16","key":"10.1016\/j.coi.2025.102580_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102580_bib7","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/jdv.19162","article-title":"Topical ruxolitinib: a new treatment for vitiligo","volume":"37","author":"Tavoletti","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2025.102580_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the pathogenesis of vitiligo","volume":"97","author":"Marchioro","year":"2022","journal-title":"Bras Dermatol"},{"key":"10.1016\/j.coi.2025.102580_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coi.2025.102580_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pmbts.2023.03.006","article-title":"Epigenetic control of heredity","volume":"198","author":"Kachhawaha","year":"2023","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.coi.2025.102580_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2133.2010.09919.x","article-title":"Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo","volume":"163","author":"Zhao","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102580_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.587440","article-title":"Transcriptome and differential methylation integration analysis identified important differential methylation annotation genes and functional epigenetic modules related to vitiligo","volume":"12","author":"Pu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102580_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115753","article-title":"Insights into DNMT1 and programmed cell death in diseases","volume":"168","author":"Yan","year":"2023","journal-title":"Biomed Pharm"},{"issue":"4","key":"10.1016\/j.coi.2025.102580_bib14","article-title":"Misregulation of the expression and activity of DNA methyltransferases in cancer","volume":"3","author":"Ik","year":"2021","journal-title":"NAR Cancer"},{"key":"10.1016\/j.coi.2025.102580_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030771","article-title":"Nutriepigenomics in environmental-associated oxidative stress","volume":"12","author":"Rubio","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.coi.2025.102580_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/epi.09.45","article-title":"Effects of arsenic exposure on DNA methylation and epigenetic gene regulation","volume":"2","author":"Reichard","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.coi.2025.102580_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cdd.2015.117","article-title":"Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo","volume":"23","author":"Shi","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2025.102580_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jdermsci.2024.02.009","article-title":"Oxidative stress-induced hypermethylation and low expression of ANXA2R: Novel insights into the dysfunction of melanocytes in vitiligo","volume":"114","author":"Chen","year":"2024","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.coi.2025.102580_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156577","article-title":"DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype","volume":"7","author":"Sanna","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102580_bib20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1242\/dev.031989","article-title":"FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism","volume":"136","author":"Thomas","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.coi.2025.102580_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091117","article-title":"The role of DNMT methyltransferases and TET dioxygenases in the maintenance of the DNA methylation level","volume":"14","author":"Davletgildeeva","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.coi.2025.102580_bib22","article-title":"Role of histone post-translational modifications in inflammatory diseases","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102580_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238894","article-title":"The role of histone acetylation-\/methylation-mediated apoptotic gene regulation in hepatocellular carcinoma","volume":"21","author":"Rajan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102580_bib24","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.7150\/thno.30398","article-title":"SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo","volume":"9","author":"Yi","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.coi.2025.102580_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051803","article-title":"The interplay between DNA and histone methylation: molecular mechanisms and disease implications","volume":"22","author":"Li","year":"2021","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coi.2025.102580_bib26","article-title":"Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription","volume":"2011","author":"Rajendran","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.coi.2025.102580_bib27","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms14023834","article-title":"Crosstalk between oxidative stress and SIRT1: impact on the aging process","volume":"14","author":"Salminen","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102580_bib28","doi-asserted-by":"crossref","first-page":"20491","DOI":"10.1074\/jbc.M112.354761","article-title":"Microphthalmia-associated transcription factor (MITF) promotes differentiation of human retinal pigment epithelium (RPE) by regulating microRNAs-204\/211 expression","volume":"287","author":"Adijanto","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102580_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2023.152011","article-title":"Effects of MITF on marker protein expression of multivesicular bodies and miRNA omics of extracellular vesicles of mice melanocyte cell line","volume":"125","author":"Zhao","year":"2023","journal-title":"Acta Histochem"},{"key":"10.1016\/j.coi.2025.102580_sbref30","article-title":"Exosome-derived microRNAs: emerging players in vitiligo","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102580_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17770-3","article-title":"Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo","volume":"12","author":"Abdallah","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102580_sbref32","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5415","article-title":"miR\u2011155 promotes an inflammatory response in HaCaT cells via the IRF2BP2\/KLF2\/NF\u2011\u03baB pathway in psoriasis","volume":"54","author":"Chen","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.coi.2025.102580_bib33","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s10528-023-10334-8","article-title":"Identification of lncRNA-miRNA-mRNA regulatory network and therapeutic agents for skin aging by bioinformatics analysis","volume":"61","author":"Xiao","year":"2023","journal-title":"Biochem Genet"},{"key":"10.1016\/j.coi.2025.102580_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028399","article-title":"Expression patterns of long non-coding RNAs in peripheral blood mononuclear cells of non-segmental vitiligo","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.coi.2025.102580_bib35","first-page":"785","article-title":"Expression profile and bioinformatics analysis of circular RNAs in patients with vitiligo","volume":"15","author":"Zhang","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.coi.2025.102580_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02030-9","article-title":"Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application","volume":"9","author":"Chen","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.coi.2025.102580_bib37","article-title":"Chromatin accessibility profiling methods","volume":"1","author":"Minnoye","year":"2021","journal-title":"Nat Rev Methods Prim"},{"key":"10.1016\/j.coi.2025.102580_bib38","article-title":"Dynamic chromatin accessibility modeled by Markov process of randomly-moving molecules in the 3D genome","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2025.102580_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41577-022-00774-5","article-title":"Three-dimensional genome organization in immune cell fate and function","volume":"23","author":"Cuartero","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2025.102580_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.molcel.2022.01.023","article-title":"HiCAR is a robust and sensitive method to analyze open-chromatin-associated genome organization","volume":"82","author":"Wei","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.coi.2025.102580_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13164919","article-title":"Role of cytokines and chemokines in vitiligo and their therapeutic implications","volume":"13","author":"K\u0105dziela","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2025.102580_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.coi.2025.102580_bib43","doi-asserted-by":"crossref","unstructured":"Exosomes Enriched With miR-31-3p From Keratinocytes Under Oxidative Stress Promote Vitiligo Progression by Destructing Melanocytes and Activating CD8+ T Cells; International Journal of Biological Macromolecules. 2025;310:143070. doi:10.1016\/j.ijbiomac.2025.143070.","DOI":"10.1016\/j.ijbiomac.2025.143070"},{"key":"10.1016\/j.coi.2025.102580_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.coi.2025.102580_bib45","first-page":"969","article-title":"The study on inhibition of 5-AZA on human uveal melanoma cell proliferation","volume":"17","author":"Yi-rui","year":"2019","journal-title":"zhqkyx"},{"key":"10.1016\/j.coi.2025.102580_sbref45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116972","article-title":"HDAC8 as a target in drug discovery: function, structure and design","volume":"280","author":"Zhao","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.coi.2025.102580_bib47","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.coi.2025.102580_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.coi.2025.102580_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03113-7","article-title":"A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework","volume":"23","author":"Gressler","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.coi.2025.102580_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjd.14878","article-title":"Interferon-inducible T-cell alpha chemoattractant (ITAC) induces the melanocytic migration and hypopigmentation through destabilizing p53 via histone deacetylase 5: a possible role of ITAC in pigment-related disorders","volume":"176","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102580_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/exd.14502","article-title":"Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis","volume":"31","author":"Samuelov","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102580_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2022.110056","article-title":"Development and expansion of the CRISPR\/Cas9 toolboxes for powerful genome engineering in yeast","volume":"159","author":"Cai","year":"2022","journal-title":"Enzym Micro Technol"},{"key":"10.1016\/j.coi.2025.102580_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114454","article-title":"The anti-melanogenic effects of ellagic acid through induction of autophagy in melanocytes and suppression of UVA-activated \u03b1-MSH pathways via Nrf2 activation in keratinocytes","volume":"185","author":"Yang","year":"2021","journal-title":"Biochem Pharm"},{"key":"10.1016\/j.coi.2025.102580_sbref53","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120549","article-title":"Tofacitinib combined with melanocyte protector \u03b1-MSH to treat vitiligo through dextran based hydrogel microneedles","volume":"305","author":"Liang","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.coi.2025.102580_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00439-023-02630-5","article-title":"Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population","volume":"143","author":"Liu","year":"2024","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2025.102580_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","article-title":"Atlas of the plasma proteome in health and disease in 53,026 adults","volume":"188","author":"Deng","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102580_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-023-00419-1","article-title":"N\u202f=\u202f1 Collaborative. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.coi.2025.102580_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2025.01.002","article-title":"Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy","author":"Peng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2025.102580_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/exd.13376","article-title":"Bioprinting of biomimetic skin containing melanocytes","volume":"27","author":"Min","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102580_sbref59","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-023-00415-5","article-title":"3D biofabrication of diseased human skin models in vitro","volume":"27","author":"Ahn","year":"2023","journal-title":"Biomater Res"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:06:20Z","timestamp":1779084380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S0952791525000561"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102580","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic regulation in vitiligo: mechanisms, challenges, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102580"}}